CZM reported mixed Q3 results. Despite some near-term headwinds, CZM managed to report healthy double-digit sales growth. While profitability witnessed sequential improvements, it is now guided at the lower-end of the previous guidance. On the other hand, the rebound in Chinese procedure volume supports a healthy growth outlook for the ongoing summer season. Overall, with intact innovation prowess, gradual supply-chain improvements and promising market dynamics, our positive recommendation is re ....
